Project Manager at King's College London. Olga manages a portfolio of clinical studies and commercial trials for patients with dementia with Lewy bodies (DLB) and Mild Cognitive Impairment (MCI) due to Alzheimer’s disease, at Old Age Psychiatry, King’s College London. She is responsible for setting up the studies, recruitment and completing clinical/cognitive assessments with patients. Her main research interest lies within understanding better how clinical and biological markers affect the disease trajectory in DLB patients. Specifically, how biomarkers associated with Alzheimer’s disease pathology affect the rate of cognitive decline in DLB patients (ENLIST-UK & EPND study, my PhD). At KCL, they are also involved in clinical trials looking at disease modifying treatments, which aim to reduce amyloid beta plaques in patients with prodromal AD (Abate study).